Trial
NCT00544908
Dasatinib in Treating Patients With Stage IV Pancreatic Cancer
Phase IITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
City of Hope Medical Center
Collaborators
National Cancer Institute (NCI)
Condition
Pancreatic Cancer
Intervention
dasatinib
Why stopped
Toxicity
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-10-05